Incidence of cerebral small vessel disease-related MR markers in the Swedish general population 'Good Aging in Skåne'(GÅS) study.
Cerebral small vessel disease
Epidemiology
Incidence
Risk-factor
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
18 Jul 2024
18 Jul 2024
Historique:
received:
24
05
2024
accepted:
04
07
2024
revised:
01
07
2024
medline:
19
7
2024
pubmed:
19
7
2024
entrez:
18
7
2024
Statut:
aheadofprint
Résumé
Cerebral small vessel disease (CSVD) is associated to cognitive decline and dementia. Neuroimaging changes of CSVD are highly prevalent above 80 years. Only few studies report on incidence of CSVD in high age. We have investigated the incidence and prevalence of magnetic resonance imaging (MRI) markers of CSVD and risk factors in the general older population. As part of the general population Good Aging in Skåne cohort study (GÅS), 241 persons (mean age 76.3 years) underwent two brain MRI, 3-T scanner with a mean interval of 5.9 years. The incidence of white matter hyperintensities (WMH), lacunar infarction, cerebral atrophies and cerebral microbleeds (CMB) were calculated and the relationship to risk factors analysed by a multivariate regression analysis. Medial temporal lobe atrophy (MTA) was graded according to Scheltens'18 scale and CMB were defined as having > 1 small (0.2-0.5 cm) hypointense lesion. The 6-year incidence of CMB, WMH and MTA were, 19%, 17% and 13% respectively, corresponding to 170/1,000 py., 172/1,000 py., and respectively 167/1,000 py. The incidence of CSVD according to the modified STRIVE score was 33%, 169/1,000 py and the prevalence at baseline was 73%. Moderate to high intake of alcohol was related to increased incidence of MTA and higher STRIVE score. Exposure to smoking was related to higher incidence of CMB and higher STRIVE score, adjusted for other known risk factors. CSVD is highly prevalent in the general older population and the 6-year incidence of WMH, CMB and MTA ranges from 13 to 19 percent. The modifiable lifestyle factors: smoking, and moderate alcohol intake are related to incident CSVD.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
Cerebral small vessel disease (CSVD) is associated to cognitive decline and dementia. Neuroimaging changes of CSVD are highly prevalent above 80 years. Only few studies report on incidence of CSVD in high age. We have investigated the incidence and prevalence of magnetic resonance imaging (MRI) markers of CSVD and risk factors in the general older population.
METHODS
METHODS
As part of the general population Good Aging in Skåne cohort study (GÅS), 241 persons (mean age 76.3 years) underwent two brain MRI, 3-T scanner with a mean interval of 5.9 years. The incidence of white matter hyperintensities (WMH), lacunar infarction, cerebral atrophies and cerebral microbleeds (CMB) were calculated and the relationship to risk factors analysed by a multivariate regression analysis. Medial temporal lobe atrophy (MTA) was graded according to Scheltens'18 scale and CMB were defined as having > 1 small (0.2-0.5 cm) hypointense lesion.
RESULTS
RESULTS
The 6-year incidence of CMB, WMH and MTA were, 19%, 17% and 13% respectively, corresponding to 170/1,000 py., 172/1,000 py., and respectively 167/1,000 py. The incidence of CSVD according to the modified STRIVE score was 33%, 169/1,000 py and the prevalence at baseline was 73%. Moderate to high intake of alcohol was related to increased incidence of MTA and higher STRIVE score. Exposure to smoking was related to higher incidence of CMB and higher STRIVE score, adjusted for other known risk factors.
CONCLUSION
CONCLUSIONS
CSVD is highly prevalent in the general older population and the 6-year incidence of WMH, CMB and MTA ranges from 13 to 19 percent. The modifiable lifestyle factors: smoking, and moderate alcohol intake are related to incident CSVD.
Identifiants
pubmed: 39026021
doi: 10.1007/s00415-024-12562-3
pii: 10.1007/s00415-024-12562-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medicinska Forskningsrådet
ID : 2017-01613
Organisme : Medicinska Forskningsrådet
ID : 2021-01437
Organisme : Medicinska Forskningsrådet
ID : 2021-00178
Informations de copyright
© 2024. The Author(s).
Références
Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF (2019) CNS small vessel disease: a clinical review. Neurology 11:1146–1156. https://doi.org/10.1212/WNL.0000000000007654
doi: 10.1212/WNL.0000000000007654
Pasi M, Cordonnier C (2020) Clinical relevance of cerebral small vessel diseases. Stroke. https://doi.org/10.1161/STROKEAHA.119.024148
doi: 10.1161/STROKEAHA.119.024148
pubmed: 32517581
pmcid: 7311289
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR et al (2013) STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12:822–838. https://doi.org/10.1016/S1474-4422(13)70124-8
doi: 10.1016/S1474-4422(13)70124-8
pubmed: 23867200
pmcid: 3714437
Singh A, Bonnell G, De Prey J, Buchwald N, Eskander K, Kincaid K, Wilson C (2023) Small-vessel disease in the brain. Am Heart J Plus Cardiol Res Pract 27:100277. https://doi.org/10.1016/j.ahjo.2023.100277
doi: 10.1016/j.ahjo.2023.100277
Kalaria RN, Akinyemi RO, Paddick SM, Ihara M (2024) Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health. Expert Rev Neurother 24:25–44. https://doi.org/10.1080/14737175.2023.2273393
doi: 10.1080/14737175.2023.2273393
pubmed: 37916306
Wang Z, Chen Q, Chen J, Yang N, Zheng K (2021) Risk factors of cerebral small vessel disease: A systematic review and meta-analysis. Medicine (Baltimore) 23:10028229. https://doi.org/10.1097/MD.0000000000028229
doi: 10.1097/MD.0000000000028229
Jacob MA, Cai M, van de Donk V, Bergkamp M, Marques J, Norris DG, Kessels RPC, Claassen JAHR, Duering M, Tuladhar AM, Leeuw FE (2023) Cerebral small vessel disease progression and the risk of dementia: a 14-year follow-up study. Am J Psychiatry 180(7):508–518. https://doi.org/10.1176/appi.ajp.20220380
doi: 10.1176/appi.ajp.20220380
pubmed: 37073486
van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM (2008) Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam scan study. Stroke 39:2712–2719. https://doi.org/10.1161/STROKEAHA.107.513176
doi: 10.1161/STROKEAHA.107.513176
pubmed: 18635849
Poels MM, Ikram MA, van der Lugt A, Hofman A, Krestin GP, Breteler MM, Vernooij MW (2011) Incidence of cerebral microbleeds in the general population: the Rotterdam scan study. Stroke 42(3):656–661. https://doi.org/10.1161/STROKEAHA.110.607184
doi: 10.1161/STROKEAHA.110.607184
pubmed: 21307170
Ekström H, Elmståhl S (2006) Pain and fractures are independently related to lower walking speed and grip strength: results from the population study “Good Ageing in Skåne.” Acta Orthop 6:902–911
doi: 10.1080/17453670610013204
Lagergren M, Fratiglioni L, Hallberg IR, Berglund J, Elmståhl S, Hagberg B, Holst G, Rennemark M, Sjolund BM, Thorslund M et al (2004) A longitudinal study integrating population, care and social services data. The Swedish National study on Aging and Care (SNAC). Aging Clin Exp Res 16:158–168
doi: 10.1007/BF03324546
pubmed: 15195992
Elmståhl S, Ellstrom K, Siennicki-Lantz A, Abul-Kasim K (2019) Association between cerebral microbleeds and hypertension in the Swedish general population “Good Aging in Skåne” study. J Clin Hypertens 21(8):1099–1107
doi: 10.1111/jch.13606
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612
doi: 10.7326/0003-4819-150-9-200905050-00006
pubmed: 19414839
pmcid: 2763564
Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, Wallin A, Ader H, Leys D, Pantoni L et al (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32(6):1318–1322
doi: 10.1161/01.STR.32.6.1318
pubmed: 11387493
Offenbacher H, Fazekas F, Schmidt R, Koch M, Fazekas G, Kapeller P (1996) MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol 17(3):573–578
pubmed: 8881257
pmcid: 8337976
Koedam EL, Lehmann M, van der Flier WM, Scheltens P, Pijnenburg YA, Fox N, Barkhof F, Wattjes MP (2011) Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol 21(12):2618–2625
doi: 10.1007/s00330-011-2205-4
pubmed: 21805370
pmcid: 3217148
Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P (1996) Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 36(5):268–272. https://doi.org/10.1159/000117270
doi: 10.1159/000117270
pubmed: 8864706
Duering M, Biessels GJ, Brodtmann A, Chen C, Cordonnier C, de Leeuw FE, Debette S, Frayne R, Jouvent E, Rost NS et al (2023) Neuroimaging standards for research into small vessel disease-advances since 2013. Lancet Neurol 22(7):602–618. https://doi.org/10.1016/S1474-4422(23)00131-X
doi: 10.1016/S1474-4422(23)00131-X
pubmed: 37236211
Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jäger HR, Werring DJ (2009) The microbleed anatomical rating scale (MARS): reliability of a tool to map brain microbleeds. Neurology 73(21):1759–1766. https://doi.org/10.1212/WNL.0b013e3181c34a7d
doi: 10.1212/WNL.0b013e3181c34a7d
pubmed: 19933977
Poels MM, Vernooij MW, Ikram MA, Hofman A, Krestin GP, van der Lugt A, Breteler MM (2010) Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke 41(10 Suppl):S103–S106. https://doi.org/10.1161/STROKEAHA.110.595181
doi: 10.1161/STROKEAHA.110.595181
pubmed: 20876479
Satizabal CL, Zhu YC, Mazoyer B, Dufouil C, Tzourio C (2012) Circulating IL-6 and CRP are associated with MRI findings in the elder: the 3C-Dijon Study. Neurology 78(10):720–727. https://doi.org/10.1212/WNL.0b013e318248e50f
doi: 10.1212/WNL.0b013e318248e50f
pubmed: 22357713
Mu R, Qin X, Guo Z, Meng Z, Liu F, Zhuang Z, Zheng W, Li X, Yang P, Feng Y, Jiang Y, Zhu X (2022) Prevalence and consequences of cerebral small vessel diseases: a cross-sectional study based on community people plotted against 5-yar age strata. Neuropsychiatr Dis Treat 18:499–512
doi: 10.2147/NDT.S352651
pubmed: 35264852
pmcid: 8901253
Kannus P, Parkkari J, Sievänen H, Heinonen A, Vuori I, Järvinen M (1996) Epidemiology of hip fractures. Bone 18(1 Suppl):57S-63S. https://doi.org/10.1016/8756-3282(95)00381-9
doi: 10.1016/8756-3282(95)00381-9
pubmed: 8717549
Roger VL, Go AS, Lloyd-Jones DM et al (2011) Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 123:e18–e209. https://doi.org/10.1161/CIR.0b013e3182009701
doi: 10.1161/CIR.0b013e3182009701
pubmed: 21160056
Jeong SM, Lee HR, Han K, Jeon KH, Kim D, Yoo JE, Cho MH, Chun S, Lee SP, Nam KW, Shin DW (2022) Association of change in alcohol consumption with risk of ischemic stroke. Stroke 53(8):2488–2496. https://doi.org/10.1161/STROKEAHA.121.037590
doi: 10.1161/STROKEAHA.121.037590
pubmed: 35440171
Chattopadhyay S, Srivastava M, Srivastava AS, Srivastava A (2011) Structural changes in the insular cortex in alcohol dependence: a cross sectional study. Iran J Psychiatry 6(4):133–137
pubmed: 22952538
pmcid: 3395958
Markus HS, de Leeuw FE (2023) Cerebral small vessel disease: Recent advances and future directions. Int J Stroke 18(1):4–14. https://doi.org/10.1177/17474930221144911
doi: 10.1177/17474930221144911
pubmed: 36575578